Sectors
RPID
Rapid Micro Biosystems, Inc.
1.12
4 x 1.14
2 x 1.48
bid
ask
+
0.03
2.75%
3 @ 05:35 PM
1.15 +0.03 (2.68%)
| Ytd | -61.38% | |
| 1y | -65.22% |
1.09
day range
1.20
1.09
52 week range
4.94
| Open | 1.11 | Prev Close | 1.09 | Low | 1.09 | High | 1.20 | Mkt Cap | 56.18M |
| Vol | 721.10K | Avg Vol | 245.96K | EPS | -1.11 | P/E | N/A | Forward P/E | -1.02 |
| Beta | 1.08 | Short Ratio | 0.38 | Inst. Own | 57.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-06 | 50-d Avg | 1.71 | 200-d Avg | 2.61 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 8.05M | ||
| Revenues (USD) | 8.05M | ||
| Cost of Revenue | 6.84M | ||
| Gross Profit | 1.21M | ||
| Operating Expenses | 13.53M | ||
| Research and Development Expense | 3.33M | ||
| Selling, General and Administrative Expense | 10.20M | ||
| Operating Income | -12.32M | ||
| Interest Expense | 646.00K | ||
| Income Tax Expense | 45.00K | ||
| Net Income | -12.92M | ||
| Net Income Common Stock | -12.92M | ||
| Net Income Common Stock (USD) | -12.92M | ||
| Consolidated Income | -12.92M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -12.23M | ||
| Earning Before Interest & Taxes (USD) | -12.23M | ||
| Weighted Average Shares | 48.35M | ||
| Weighted Average Shares Diluted | 48.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.97M | ||
| Cash and Equivalents (USD) | 14.97M | ||
| Investments | 5.08M | ||
| Investments Current | 5.08M | ||
| Trade and Non-Trade Receivables | 5.52M | ||
| Current Assets | 46.26M | ||
| Property, Plant & Equipment Net | 11.73M | ||
| Total Assets | 58.45M | ||
| Debt Current | 1.34M | ||
| Total Debt | 23.48M | ||
| Current Liabilities | 18.15M | ||
| Debt Non-Current | 22.14M | ||
| Total Liabilities | 40.70M | ||
| Accumulated Retained Earnings (Deficit) | -549.59M | ||
| Accumulated Other Comprehensive Income | -1000 | ||
| Shareholders Equity | 17.75M | ||
| Shareholders Equity (USD) | 17.75M | ||
| Assets Non-Current | 12.19M | ||
| Total Debt (USD) | 23.48M | ||
| Deferred Revenue | 5.51M | ||
| Inventory | 18.92M | ||
| Liabilities Non-Current | 22.55M | ||
| Trade and Non-Trade Payables | 5.18M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 978.00K | ||
| Net Cash Flow from Financing | 9.35M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 872.00K | ||
| Capital Expenditure | 223.00K | ||
| Issuance (Purchase) of Equity Shares | 9.46M | ||
| Issuance (Repayment) of Debt Securities | -9.00K | ||
| Net Cash Flow from Investing | 4.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.00M | ||
| Net Cash Flow from Operations | -12.70M | ||
| Share Based Compensation | 1.32M | ||